In a landmark development for artificial intelligence in scientific research, a new perspective paper published in the prestigious journal npj Systems Biology and Applications, part of the Nature portfolio, has highlighted groundbreaking Indo-Japan collaboration aimed at realizing the ambitious Nobel Turing Challenge. Titled "Creating an engine of scientific discovery, an Indo-Japan perspective: learnings from IJNTC 2025 workshop," the paper, released on April 22, 2026, synthesizes insights from a pivotal workshop held in Tokyo, bringing together top researchers from both nations to push the boundaries of AI-driven autonomous scientific discovery.
The Nobel Turing Challenge, first proposed by Hiroaki Kitano in a seminal 2021 Nature paper, envisions developing highly autonomous AI systems—dubbed 'AI Scientists'—capable of conducting top-level research indistinguishable from that of leading human scientists, potentially yielding discoveries worthy of Nobel Prizes. This challenge seeks to transcend human cognitive limitations by creating an 'engine' for continuous, scalable scientific breakthroughs, particularly in complex fields like biomedicine and systems biology.
The recent Indo-Japan workshop, known as IJNTC2025 (India-Japan Meeting on the Nobel Turing Challenge), convened on March 24-25, 2025, at the Central Gotanda Building in Tokyo. Organized by The Systems Biology Institute (SBI) Japan, it featured 19 presentations and round-table discussions, fostering synergies between Japan's precision robotics and AI expertise and India's vast data resources and frugal innovation approaches. Key Indian participants included professors Tavpritesh Sethi and Ganesh Bagler from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), Satish Kottapalli from Global Health X in Hyderabad, Ajay Sethi from Open Science Stack in Bengaluru, and Srinivas Padmanabhan from SRM Technologies in Chennai, alongside Ravindranath Kancherla from the Global Institute for Research & Innovation in Hyderabad.
Background: The Nobel Turing Challenge and Its Grand Vision
The Nobel Turing Challenge (NTC) represents a paradigm shift in scientific methodology. Traditional science relies on human intuition, hypothesis-driven experimentation, and serendipity, often constrained by time, resources, and cognitive biases. NTC proposes an alternative: AI systems that exhaustively explore vast hypothesis spaces, automate experiments, and self-improve through closed-loop learning.
Kitano's original framework outlines core components: advanced knowledge representation (e.g., probabilistic multiverse knowledge graphs), hypothesis generation via generative models and reinforcement learning, robotic laboratory automation for high-throughput testing, and communication modules for publishing and collaboration. By 2050, NTC aims for AI achieving Nobel-caliber discoveries, such as novel biomedical mechanisms or therapeutic targets, accelerating progress in areas like drug discovery and personalized medicine.
In India, where research output has surged—with over 1.5 million research papers annually and institutions like IIIT-Delhi leading in computational biology—this challenge resonates deeply. Indian researchers bring expertise in handling massive, diverse datasets from national initiatives like Ayushman Bharat Digital Mission and ICMR biobanks, enabling scalable AI training.
The IJNTC2025 Workshop: A Catalyst for Collaboration
Hosted by SBI Japan under Hiroaki Kitano's leadership, the workshop drew speakers from premier institutions: RIKEN (Japan), OIST (Okinawa), Sony AI (Tokyo), Nagasaki University, and Indian hubs like IIIT-Delhi and SRM. Flash talks covered cutting-edge topics, from AI-guided DNA damage response analysis (Anton Kratz, Nagasaki) to poverty-alleviating cancer care AI in low-middle-income countries (Harikeshav P, Kavi Healthcare).
Key Themes Emerging from Indo-Japan Synergies
The paper distills four pivotal themes:
- Knowledge Extraction: Automating extraction of actionable insights from literature and data. Japanese tools like AI-augmented labs (Ryota Yamada, Fuku Inc.) parse papers for protocols, while Indian platforms like Open Science Stack handle multi-omics integration.
- Laboratory Automation: Japan's robotics prowess—e.g., OIST's automated multi-omics platforms and Epistra's Bayesian optimization for experiments (Yosuke Ozawa)—pairs with India's cost-effective scaling for high-volume testing.
- Hypothesis Generation: Temporal graph models for link prediction (Combinatics Inc., Japan) and SHOE/AGCT for transcriptional regulation (Natalia Polouliakh, Sony CSL), enhanced by IIIT-Delhi's network biology approaches.
- Equitable Healthcare Applications: Frugal AI for antimicrobial resistance surveillance (IIIT-Delhi) and pediatric care, leveraging India's diverse patient data and Japan's precision diagnostics.
These themes underscore how bilateral efforts can build 'world models' for autonomous discovery, addressing NTC's core challenges.
India's Pivotal Role: Data Power and Frugal Innovation
Indian institutions shine in NTC pursuits. IIIT-Delhi's Computational Biology group, led by Sethi and Bagler, excels in graph-based hypothesis generation and microbiome analysis, vital for biomedicine. Their involvement signals India's rising AI-for-science ecosystem, bolstered by IndiaAI Mission's compute infrastructure and ANRF funding.
Frugal innovation—developing robust solutions at low cost—is India's edge. Examples include Global Health X's AI for poverty-linked health burdens and SRM's ethical AI frameworks. With 1.4 billion people generating unparalleled health data diversity, India positions itself as NTC's data backbone. Recent initiatives like LOTUS 2026 invite 1,000 Indian researchers to Japan, amplifying momentum.
For Indian universities, this means enhanced global visibility. IIIT-Delhi, IITs, and IISERs can leverage such collaborations for joint grants, student exchanges, and AI labs, aligning with NEP 2020's research thrust.
Japan's Strengths: Robotics and Precision AI
Japan contributes unmatched hardware: Sony AI's reinforcement learning for hypothesis exploration, RIKEN's integrative medical sciences, and OIST's robotics. Tools like Percellome for toxicogenomics and CellKb for immune cell annotation exemplify precision enabling NTC's experimental loop.
The workshop's Japanese flash talks, e.g., Manas Kala's (Veritus AI/Osaka U) view of AI as a 'shovel' for researchers, highlight productivity boosts. This precision dovetails with India's scale, promising hybrid systems for drug discovery and epidemiology.
Implications for Indian Higher Education and Research
This Nature paper elevates Indian academia on the global stage. Institutions like IIIT-Delhi exemplify how public-private partnerships—e.g., with SBI Japan—drive frontier research. For students, it opens doors to interdisciplinary PhDs in AI-biomedicine, with skills in graph ML and automation in high demand.
Challenges persist: India's researcher density lags (156 per million vs. Japan's 5,000+), but collaborations bridge gaps. Funding via DBT, DST, and international grants like ONR (supporting IJNTC) can scale labs. NEP's multidisciplinary focus prepares youth for NTC-era roles.
Read the full paper for deeper insights: Nature npj Systems Biology.
Broader Impacts: Transforming Biomedicine and Beyond
NTC progress promises revolutions: AI accelerating drug repurposing (e.g., antimicrobial resistance, critical in India with 1.3M TB deaths yearly), digital twins for personalized medicine, and equitable AI mitigating LMIC burdens. Indo-Japan models could extend to climate modeling or materials science.
Ethical considerations loom: bias mitigation, explainability, and open science. The workshop emphasized trustworthy AI, aligning with India's AI ethics framework.
Future Outlook: Roadmaps and Next Steps
The paper calls for joint funding, shared platforms, and pilot 'AI Scientist' labs. With LOTUS 2026 and India-Japan S&T pacts, expect more workshops, joint papers, and prototypes by 2030.
For Indian researchers, this is a clarion call: integrate AI into curricula, build robotics infra, and partner globally. As Kitano notes, NTC isn't replacing scientists but augmenting them for unprecedented discovery rates.
Photo by Caroline Roose on Unsplash
This Indo-Japan endeavor via the Nature paper not only spotlights NTC but ignites hope for AI-powered science transforming healthcare. Indian universities stand at the vanguard, ready to contribute data-scale innovation to global challenges.